- Countries
- World
- S&P Global Ratings assigns investment grade rating to Sartorius
S&P Global Ratings assigns investment grade rating to Sartorius
29 August 2023 | Tuesday | News
In its first credit rating, the life science group Sartorius has received a solid investment grade rating. The international rating agency S&P Global Ratings assigned a long-term issuer rating of BBB with a stable outlook. The rating agency particularly acknowledged Sartorius' leading portfolio for life science and biopharma applications, its global reach, strong market fundamentals, and the Sartorius management’s high financial discipline
- Initial rating for Sartorius: Long-term BBB issuer rating with stable outlook
- S&P Global Ratings highlights Sartorius’ operational strength, financial discipline, and healthy end markets
"The rating underlines the investment quality of our company and provides a sound basis for the Group's future access to broader capital markets," said Rainer Lehmann, CFO and member of the Executive Board of Sartorius.